Emilia Jaskuła

The presence of <i>IFNG</i> 3/3 genotype in the recipient associates with increased risk for Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation

Katarzyna Bogunia‐Kubik, Anna Mlynarczewska, Emilia Jaskuła et al. · British Journal of Haematology · 2005 · 38 citations

Life Sciences, Genetics, Immunology +14

Role of Donor Activating KIR–HLA Ligand–Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients

Jacek Nowak, Katarzyna Kościńska, Renata Mika‐Witkowska et al. · Biology of Blood and Marrow Transplantation · 2015 · 34 citations · Full text

Life Sciences, Hematology, Immunology +15

Interferon Gamma 13-CA-Repeat Homozygous Genotype and a Low Proportion of CD4+ Lymphocytes Are Independent Risk Factors for Cytomegalovirus Reactivation with a High Number of Copies in Hematopoietic Stem Cell Transplantation Recipients

Emilia Jaskuła, Dorota Dłubek, Dorota Duda et al. · Biology of Blood and Marrow Transplantation · 2009 · 28 citations · Full text

Life Sciences, Hematology, Immunology +16

Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients

Jacek Nowak, Katarzyna Kościńska, Renata Mika‐Witkowska et al. · American Journal of Hematology · 2014 · 27 citations · Full text

Life Sciences, Hematology, Immunology +17

CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients

Emilia Jaskuła, J Bocheńska, Edyta Kocwin et al. · Bone Marrow Research · 2012 · 26 citations · Full text

Medicine, Immunology, Infectious Diseases +17